Bridge Biotherapeutics Confident In IPF Contender As It Seeks Global Partner

Big Pharma Licensing Talks Underway

 
• By Jung Won Shin
  
James Jungkue Lee, President and CEO of Bridge Biotherapeutics Inc.
First Korean Bioventure To Speak At The Main JPM Healthcare Conference Session (Bridge Biotherapeutics Inc.)

More from South Korea

More from Therapy Areas